Shanghai Bovax Biotechnology Co., Ltd. | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years	DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, anogenital human papillomavirus infection, common wart, human papilloma virus infection, infectious disease, sexually transmitted disease, skin disorder, skin disorder caused by infection, viral infectious disease, viral sexually transmitted disease	Recruiting	Phase 2	2025-12-17		NCT06756269
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males	Anal Cancer, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Genital Diseases, Infections, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, anogenital human papillomavirus infection, anus disorder, anus neoplasm, colorectal neoplasm, common wart, digestive system disorder, digestive system neoplasm, human papilloma virus infection, infectious disease, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm, rectal disorder, rectal neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 3	2024-12-12		NCT06465914
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, androgen insensitivity syndrome, non-human animal, anogenital human papillomavirus infection, cervix disorder, common wart, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, low grade vulvar intraepithelial neoplasia, neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, uterine disorder, vaginal cancer, vaginal disorder, viral infectious disease, viral sexually transmitted disease, vulva cancer, vulvar disease	Recruiting	Phase 3	2024-06-07		NCT04422366
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine	DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, anogenital human papillomavirus infection, cervix disorder, common wart, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, uterine disorder, vaginal cancer, vaginal disorder, viral infectious disease, viral sexually transmitted disease	Recruiting	Not stated	2024-04-17		NCT05371353